Regeneron Pharmaceuticals (REGN)
Retained Earnings
$37.62B
Quarterly · Period ending: · USD
REGN Retained Earnings
Latest reported$37.62Bperiod ending
Latest reported$37.62Bperiod ending
REGN Quarterly Retained Earnings (-$7.00M → $37.62B)
Quarterly retained earnings
High-resolution chart · PNG
REGN retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -251,389,000 | |
| -236,555,000 | |
| -223,518,000 | |
| -213,779,000 | |
| -210,568,000 | |
| -207,621,000 | |
| -200,300,000 | |
| -198,900,000 | |
| -194,000,000 | |
| -186,200,000 | |
| -177,200,000 | |
| -171,700,000 | |
| -170,300,000 | |
| -172,400,000 | |
| -168,600,000 | |
| -169,100,000 | |
| -167,200,000 | |
| -163,000,000 | |
| -157,000,000 | |
| -148,900,000 | |
| -140,000,000 | |
| -132,400,000 | |
| -124,600,000 | |
| -116,800,000 | |
| -109,600,000 | |
| -105,300,000 | |
| -101,100,000 | |
| -95,400,000 | |
| -91,400,000 | |
| -81,200,000 | |
| -70,400,000 | |
| -58,900,000 | |
| -49,300,000 | |
| -39,900,000 | |
| -30,600,000 | |
| -24,200,000 | |
| -18,400,000 | |
| -14,700,000 | |
| -11,400,000 | |
| -9,300,000 | |
| -8,500,000 | |
| -7,000,000 |